Metabolic syndrome affects breast-cancer risk in postmenopausal women: National Cancer Institute of Naples experience

Cancer Biology and Therapy

Volumn 10, Issue 12, 2010, Pages 1240-1243

  Capasso, Immacolata ^a   Esposito, Emanuela ^a   Pentimalli, Francesca ^b,c   Crispo, Anna ^d   Montella, Maurizio ^d   Grimaldi, Maria ^d   De Marco, Mariarosaria ^d   Cavalcanti, Ernestina ^e   D'Aiuto, Massimiliano ^a   Fucito, Alfredo ^a   Frasci, Giuseppe ^a   Maurea, Nicola ^f   Esposito, Giuseppe ^e   Pedicini, Tonino ^a   Vecchione, Aldo ^a   D'Aiuto, Giuseppe ^a   Giordano, Antonio ^b,c,g  

^a Department of Senology ^*  (Italy)

^b Centro Ricerche Oncologiche Mercongliano   (Italy)

^c Sbarro Health Research Organization   (United States)

^d Division of Epidemiology   (Italy)

^e Division of Clinical Pathology   (Italy)

^f NATIONAL CANCER INSTITUTE   (Italy)

^g UNIVERSITY OF SIENA   (Italy)

Author keywords

Body mass index; Breast cancer; High density lipoprotein cholesterol (HDL C); Hyperandrogenic status; Hyperinsulinemia; Insulin resistance; Insulin like growth factor 1 (IGF 1); Metabolic syndrome; Postmenopausal; Weight gain

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; TESTOSTERONE; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BODY MASS; BREAST CANCER; CANCER PATIENT; CARCINOGENESIS; CASE CONTROL STUDY; CELL PROLIFERATION; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEIGHT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIFESTYLE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PREVALENCE; PRIMARY PREVENTION; TRIACYLGLYCEROL BLOOD LEVEL; VISCERA; WAIST CIRCUMFERENCE; WEIGHT;

ADULT; AGED; ALCOHOLISM; BLOOD GLUCOSE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS INDEX; BODY SIZE; BODY WEIGHT; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; FEMALE; HUMANS; INSULIN; LIFE STYLE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; POSTMENOPAUSE; QUESTIONNAIRES; RISK FACTORS; SMOKING; TESTOSTERONE; TRIGLYCERIDES; URIC ACID;

EID: 78650334747     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.10.12.13473     Document Type: Article

References (26)

1. van Gils CH, Peeters PH, Schoenmakers MC, Nijmeijer RM, Onland-Moret NC, van der Schouw YT, et al. Physical activity and endogenous sex hormone levels in postmenopausal women: a cross-sectional study in the Prospect-EPIC Cohort. Cancer Epidemiol Biomarkers Prev 2009; 18:377-83.
2. Enger SM, Ross RK, Paganini-Hill A, Carpenter CL, Bernstein L. Body size, physical activity and breast cancer hormone receptor status: results from two casecontrol studies. Cancer Epidemiol Biomarkers Prev 2000; 9:681-7.
3. Friedenreich CM, Courneya KS, Bryant HE. Case control study of anthropometric measures and breast cancer risk. Int J Cancer 2002; 99:445-52.
4. Kaaks R. Nutrition, hormones and breast cancer: is insulin the missing link? Cancer Causes Control 1996; 7:605-25.
5. Agnoli C, Berrino F, Abagnato CA, Muti P, Panico S, Crosignani P, et al. Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study. Nutr Metab Cardiovasc Dis 20:41-8.
6. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 1999; 53:83-7.
7. Wakai K, Tamakoshi K, Date C, Fukui M, Suzuki S, Lin Y, et al. Dietary intakes of fat and fatty acids and risk of breast cancer: a prospective study in Japan. Cancer Sci 2005; 96:590-9.
8. Gaard M, Tretli S, Loken EB. Dietary fat and the risk of breast cancer: a prospective study of 25,892 Norwegian women. Int J Cancer 1995; 63:13-7.
9. Lof M, Hilakivi-Clarke L, Sandin SS, de Assis S, Yu W, Weiderpass E. Dietary fat intake and gestational weight gain in relation to estradiol and progesterone plasma levels during pregnancy: a longitudinal study in Swedish women. BMC Womens Health 2009; 9:10.
10. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome. Diabetes 2004; 53:2087-94.
11. Baglietto L, Severi G, English DR, Krishnan K, Hopper JL, McLean C, et al. Circulating steroid hormone levels and risk of breast cancer for postmenopausal women. Cancer Epidemiol Biomarkers Prev 19:492-502.
12. Gillmer MD. Mechanism of action/effects of androgens on lipid metabolism. Int J Fertil 1992; 37:83-92.
13. Bruning PF, Bonfrer JM, van Noord PA, Hart AA, de Jong-Bakker M, Nooijen WJ. Insulin resistance and breast-cancer risk. Int J Cancer 1992; 52:511-6.
14. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351:1393-6.
15. Tian YF, Chu CH, Wu MH, Chang CL, Yang T, Chou YC, et al. Anthropometric measures, plasma adiponectin and breast cancer risk. Endocr Relat Cancer 2007; 14:669-77.
16. Peyrat JP, Bonneterre J, Vennin PH, Jammes H, Beuscart R, Hecquet B, et al. Insulin-like growth factor 1 receptors (IGF1-R) and IGF1 in human breast tumors. J Steroid Biochem Mol Biol 1990; 37:823-7.
17. Kaaks R. [Plasma insulin, IGF-I and breast cancer]. Gynecol Obstet Fertil 2001; 29:185-91.
18. Kabat GC, Kim M, Chlebowski RT, Khandekar J, Ko MG, McTiernan A, et al. A longitudinal study of the metabolic syndrome and risk of postmenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2009; 18:2046-53.
19. Xue F, Michels KB. Diabetes, metabolic syndrome and breast cancer: a review of the current evidence. Am J Clin Nutr 2007; 86:823-35.
20. Healy LA, Ryan AM, Carroll P, Ennis D, Crowley V, Boyle T, et al. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer. Clin Oncol (R Coll Radiol) 2010; 22:281-8.
21. Maiti B, Kundranda MN, Spiro TP, Daw HA. The association of metabolic syndrome with triple-negative breast cancer. Breast Cancer Res Treat 2010; 121:479-83.
22. Adebamowo CA, Ogundiran TO, Adenipekun AA, Oyesegun RA, Campbell OB, Akang EE, et al. Waisthip ratio and breast cancer risk in urbanized Nigerian women. Breast Cancer Res 2003; 5:18-24.
23. Furberg AS, Veierod MB, Wilsgaard T, Bernstein L, Thune I. Serum high-density lipoprotein cholesterol, metabolic profile and breast cancer risk. J Natl Cancer Inst 2004; 96:1152-60.
24. Moorman PG, Hulka BS, Hiatt RA, Krieger N, Newman B, Vogelman JH, et al. Association between high-density lipoprotein cholesterol and breast cancer varies by menopausal status. Cancer Epidemiol Biomarkers Prev 1998; 7:483-8.
25. Lupien M, Brown M. Cistromics of hormone-dependent cancer. Endocr Relat Cancer 2009; 16:381-9.
26. Rotheneder M, Kostner GM. Effects of low- and highdensity lipoproteins on the proliferation of human breast cancer cells in vitro: differences between hormone- dependent and hormone-independent cell lines. Int J Cancer 1989; 43:875-9.